BPG is committed to discovery and dissemination of knowledge
Case Control Study
©The Author(s) 2025.
World J Clin Pediatr. Dec 9, 2025; 14(4): 108068
Published online Dec 9, 2025. doi: 10.5409/wjcp.v14.i4.108068
Table 4 Laboratory data of familial Mediterranean fever patients and controls
Characteristic
Attack (n = 40)
Attack-Free (n = 40)
Controls (n = 40)
P1
P2
P3
TLC (× 10³/μL)9.91 ± 1.788.67 ± 1.016.84 ± 1.26< 0.001a< 0.001a0.009a
ESR 1st hour (mm)50.27 ± 18.9810.95 ± 6.212.35 ± 1.36< 0.001a< 0.001a< 0.001a
ESR 2nd hour (mm)75.03 ± 14.7933.25 ± 6.2917.58 ± 3.09< 0.001a< 0.001a< 0.001a
CRP (mg/L)60.93 ± 17.9826.13 ± 6.5410.07 ± 1.82< 0.001a< 0.001a< 0.001a
Amyloid A (mg/L)114.95 ± 82.276.73 ± 1.574.25 ± 1.10< 0.001a< 0.001a< 0.001a
Resistin (ng/mL)28.57 ± 6.9417.33 ± 3.0511.16 ± 5.24< 0.001a< 0.001a< 0.001a
Fibrinogen (mg/dL)630.55 ± 124.44302.77 ± 74.18234.38 ± 99.73< 0.001a< 0.001a0.042a


Write to the Help Desk